William (Bill) Grey
PhD at King's College London (with the late Dr Veronica Yu and Prof. David Grimwade) on CKS1/CKS2-controlled proteostasis across stem cell systems. Postdoc with Prof. Dominique Bonnet at the Francis Crick Institute, working on the HSC kinome, ex vivo HSC expansion, and CKS1-dependent proteostasis in AML. Now leads ProteoStem, funded by an MRC Career Development Award and others.
Anjum Khan
Consultant haematologist holding an MRC Clinical Academic Research Partnership award to lead joint projects with the lab. Research interests in AML and myeloid malignancies, allogeneic stem cell transplantation, and immunotherapy, with a focus on the mechanisms driving leukaemic stem cells and chemotherapy resistance.
Juliana Fabiani Miranda
PhD from the University of Liverpool in immuno-oncology, targeting a macrophage-derived molecule shaping the metastatic pancreatic-cancer microenvironment. Joined the Grey Lab in May 2023 to study how protein homeostasis modulates AML development and relapse.
Megan Guthrie
BSc from Warwick and MRes in Biomedical Sciences and Translational Medicine from Liverpool, working on aberrantly expressed meiotic proteins in cancer. Began her MRC-DiMeN PhD in the lab in October 2023, investigating human HSC biology and ex vivo expansion.
William Critchley
PhD in Immunology from Manchester (2017) on the passenger leukocyte reservoir in solid organ transplantation, followed by BHF-funded postdoctoral work in the Ponnambalam lab at Leeds on the post-translational control of VEGFR2. Joined the Grey Lab in April 2024 to study proteostatic vulnerabilities in human LSCs.
Kimrun Kaur
BSc and MRes from UWE Bristol on non-genotoxic therapeutics in multiple myeloma, followed by research-technician work in the Healthcare Associated Infection Research group modelling C. difficile infection. Holds a YGRS-funded PhD in the lab, investigating the protein biology of multiple myeloma at diagnosis and relapse.
